Hong Kong
· Delayed Price · Currency is HKD BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of HKD 189.31 billion. The enterprise value is 178.26 billion.
| Market Cap | 189.31B |
| Enterprise Value | 178.26B |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.29B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | -2.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 69.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 71.36 |
| PS Ratio | 5.82 |
| PB Ratio | 7.00 |
| P/TBV Ratio | 7.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 149.34 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -58.03 |
| EV / Sales | 5.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -107.43 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.95 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.16 |
| Interest Coverage | -18.93 |
Financial Efficiency
Return on equity (ROE) is -11.62% and return on invested capital (ROIC) is -3.86%.
| Return on Equity (ROE) | -11.62% |
| Return on Assets (ROA) | -3.06% |
| Return on Invested Capital (ROIC) | -3.86% |
| Return on Capital Employed (ROCE) | -7.30% |
| Revenue Per Employee | 2.96M |
| Profits Per Employee | -279,284 |
| Employee Count | 11,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.22% in the last 52 weeks. The beta is 0.35, so BeiGene's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +38.22% |
| 50-Day Moving Average | 149.05 |
| 200-Day Moving Average | 128.56 |
| Relative Strength Index (RSI) | 41.43 |
| Average Volume (20 Days) | 6,849,925 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BeiGene had revenue of HKD 32.53 billion and -3.07 billion in losses. Loss per share was -29.20.
| Revenue | 32.53B |
| Gross Profit | 27.63B |
| Operating Income | -2.17B |
| Pretax Income | -2.02B |
| Net Income | -3.07B |
| EBITDA | -811.59M |
| EBIT | -2.17B |
| Loss Per Share | -29.20 |
Balance Sheet
The company has 19.59 billion in cash and 8.57 billion in debt, giving a net cash position of 11.03 billion.
| Cash & Cash Equivalents | 19.59B |
| Total Debt | 8.57B |
| Net Cash | 11.03B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 27.03B |
| Book Value Per Share | 250.36 |
| Working Capital | 14.72B |
Cash Flow
In the last 12 months, operating cash flow was 1.27 billion and capital expenditures -2.93 billion, giving a free cash flow of -1.66 billion.
| Operating Cash Flow | 1.27B |
| Capital Expenditures | -2.93B |
| Free Cash Flow | -1.66B |
| FCF Per Share | n/a |
Margins
Gross margin is 84.94%, with operating and profit margins of -6.67% and -9.44%.
| Gross Margin | 84.94% |
| Operating Margin | -6.67% |
| Pretax Margin | -6.22% |
| Profit Margin | -9.44% |
| EBITDA Margin | -2.50% |
| EBIT Margin | -6.67% |
| FCF Margin | n/a |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.78% |
| Shareholder Yield | -0.78% |
| Earnings Yield | -1.62% |
| FCF Yield | -0.88% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |